Randomized trial · people
Larazotide: 0.5 mg arm eased celiac symptoms on gluten-free diet
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In one mid-stage trial, only the lowest larazotide dose eased celiac symptoms beyond a gluten-free diet alone, and the higher doses showed no benefit.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 342
- Published
- 2015
- Journal
- Gastroenterology
What they tested
The team tested whether larazotide acetate could ease ongoing celiac disease symptoms in adults who still had them while staying on a gluten-free diet.
How the study was done
A multicenter, randomized, double-blind, placebo-controlled phase II trial in 342 adults with celiac disease who had kept a gluten-free diet for 12 months or longer. They took 0.5, 1, or 2 mg 3 times daily or placebo (a dummy treatment) for 12 weeks, with 4 weeks on placebo before and 4 weeks on placebo after.

What they found
The 0.5 mg arm met the main goal, with fewer gut symptoms than placebo on the Celiac Disease Gastrointestinal Symptom Rating Scale. On exploratory measures, the 0.5 mg arm had 26% fewer symptomatic days, 31% more improved symptom days, more people with abdominal pain cut by 50% or more for 6 or more of the 12 weeks, and less headache and tiredness. The 1 mg and 2 mg arms did no better than placebo on any measure. Safety was similar to placebo.
What it doesn’t show
This was a 12-week phase II trial, and only the lowest dose beat placebo while the higher doses did not, so the results were mixed. Most of the extra benefits came from exploratory measures, not the main goal.
The paper
Leffler et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015.
The compound
More studies on Larazotide
- Larazotide: eased GI symptoms in celiac patients on gluten challengeMeta-analysis · people · 2022
- Larazotide sped gut symptom recovery in children with post-COVID MISCRandomized trial · people · 2025
- Larazotide: no gut permeability rise after gluten in celiac patientsRandomized trial · people · 2007
- Larazotide lowered gut leakage in rats with acute pancreatitisAnimal study · rats · 2024
- Larazotide aided tight junction assembly in MDCK and Caco-2 cellsCell study · MDCK and Caco-2 cells · 2012
- Every study on Larazotide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.